Literature DB >> 15607977

NAD+-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1.

Mi Young Kim1, Steven Mauro, Nicolas Gévry, John T Lis, W Lee Kraus.   

Abstract

PARP-1 is the most abundantly expressed member of a family of proteins that catalyze the transfer of ADP-ribose units from NAD+ to target proteins. Herein, we describe previously uncharacterized nucleosome binding properties of PARP-1 that promote the formation of compact, transcriptionally repressed chromatin structures. PARP-1 binds in a specific manner to nucleosomes and modulates chromatin structure through NAD+-dependent automodification, without modifying core histones or promoting the disassembly of nucleosomes. The automodification activity of PARP-1 is potently stimulated by nucleosomes, causing the release of PARP-1 from chromatin. The NAD+-dependent activities of PARP-1 are reversed by PARG, a poly(ADP-ribose) glycohydrolase, and are inhibited by ATP. In vivo, PARP-1 incorporation is associated with transcriptionally repressed chromatin domains that are spatially distinct from both histone H1-repressed domains and actively transcribed regions. Thus, PARP-1 functions both as a structural component of chromatin and a modulator of chromatin structure through its intrinsic enzymatic activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15607977     DOI: 10.1016/j.cell.2004.11.002

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  240 in total

1.  Re-evaluating PARP1 inhibitor in cancer.

Authors:  Alexei Tulin
Journal:  Nat Biotechnol       Date:  2011-12-08       Impact factor: 54.908

2.  Poly(ADP-ribose)polymerase-1 (PARP1) controls adipogenic gene expression and adipocyte function.

Authors:  Süheda Erener; Mareike Hesse; Radina Kostadinova; Michael O Hottiger
Journal:  Mol Endocrinol       Date:  2011-11-03

3.  Regulation of poly(ADP-ribose) polymerase-1-dependent gene expression through promoter-directed recruitment of a nuclear NAD+ synthase.

Authors:  Tong Zhang; Jhoanna G Berrocal; Jie Yao; Michelle E DuMond; Raga Krishnakumar; Donald D Ruhl; Keun Woo Ryu; Matthew J Gamble; W Lee Kraus
Journal:  J Biol Chem       Date:  2012-02-13       Impact factor: 5.157

4.  How are nucleosomes disrupted during transcription elongation?

Authors:  Jordanka Zlatanova; Jean-Marc Victor
Journal:  HFSP J       Date:  2009-11-12

5.  Niacin restriction upregulates NADPH oxidase and reactive oxygen species (ROS) in human keratinocytes.

Authors:  Claudia A Benavente; Elaine L Jacobson
Journal:  Free Radic Biol Med       Date:  2007-10-17       Impact factor: 7.376

6.  Specific Binding of snoRNAs to PARP-1 Promotes NAD+-Dependent Catalytic Activation.

Authors:  Dan Huang; Dae-Seok Kim; W Lee Kraus
Journal:  Biochemistry       Date:  2020-04-17       Impact factor: 3.162

7.  Charon Mediates Immune Deficiency-Driven PARP-1-Dependent Immune Responses in Drosophila.

Authors:  Yingbiao Ji; Colin Thomas; Nikita Tulin; Niraj Lodhi; Ernest Boamah; Vladimir Kolenko; Alexei V Tulin
Journal:  J Immunol       Date:  2016-08-15       Impact factor: 5.422

8.  Cooperation of the Cockayne syndrome group B protein and poly(ADP-ribose) polymerase 1 in the response to oxidative stress.

Authors:  Tina Thorslund; Cayetano von Kobbe; Jeanine A Harrigan; Fred E Indig; Mette Christiansen; Tinna Stevnsner; Vilhelm A Bohr
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

9.  Structural basis for allosteric PARP-1 retention on DNA breaks.

Authors:  Levani Zandarashvili; Marie-France Langelier; Uday Kiran Velagapudi; Mark A Hancock; Jamin D Steffen; Ramya Billur; Zain M Hannan; Andrew J Wicks; Dragomir B Krastev; Stephen J Pettitt; Christopher J Lord; Tanaji T Talele; John M Pascal; Ben E Black
Journal:  Science       Date:  2020-04-03       Impact factor: 47.728

10.  Poly(ADP-ribose) polymerase 1 promotes transcriptional repression of integrated retroviruses.

Authors:  Murilo T D Bueno; Daniel Reyes; Luis Valdes; Adarsh Saheba; Eduardo Urias; Crystal Mendoza; Oliver I Fregoso; Manuel Llano
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.